Ornipressin
Ornipressin is a vasopressin analogue, specifically a synthetic variant of arginine vasopressin, used in medicine for its vasoconstrictive properties. It is primarily used in the management of esophageal varices, a condition often associated with cirrhosis of the liver.
Pharmacology[edit]
Ornipressin acts on vasopressin receptors, specifically the V1 receptor subtype, to induce vasoconstriction. This action is useful in conditions where reducing blood flow is beneficial, such as in the management of esophageal varices. The drug is administered intravenously and has a rapid onset of action.
Clinical Use[edit]
The primary use of ornipressin in medicine is in the management of esophageal varices, particularly in the context of cirrhosis. By inducing vasoconstriction, ornipressin reduces blood flow to the varices, reducing the risk of rupture and subsequent hemorrhage. It may also be used in other conditions where vasoconstriction is beneficial, although these uses are less common.
Side Effects[edit]
Like all medications, ornipressin can cause side effects. These may include hypertension, bradycardia, and ischemia due to its vasoconstrictive properties. It may also cause water retention and hyponatremia due to its action on vasopressin receptors.
Contraindications[edit]
Ornipressin should not be used in patients with known hypersensitivity to the drug or any of its components. It is also contraindicated in patients with severe cardiovascular disease due to the risk of exacerbating these conditions.
See Also[edit]
Ornipressin[edit]
-
Ornipressin
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
